Effects of Upper Airway Muscle Training on OSA
2 other identifiers
interventional
134
1 country
1
Brief Summary
Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent collapse of the upper airway during sleep. OSA patients have a small upper airway that is kept patent during wakefulness by a compensatory increase in upper airway (UA) dilator muscle (e.g. genioglossus) activity. At sleep onset this compensation is reduced or lost, resulting in upper airway narrowing or collapse. Previous studies of upper airway muscle training showed variable results on OSA, but so far there has not been any practical, long-term, systematic upper airway muscle training developed or studied as the treatment of OSA. In theory, strengthening the upper airway muscle with exercise training in theory helps maintain a patent airway during sleep. Therefore, investigators aim to test the hypothesis: 1) UA muscle training can improve sleep apnea in some patients with OSA, including those already receiving treatment with PAP or oral appliance therapy. 2) Muscle training is a viable therapy for a definable subset of OSA patients. Investigators hypothesize that patients with OSA who have mild or moderately compromised upper airway anatomy will benefit the most. 3)There will be a positive association between the changes in muscle function and improvement in OSA severity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2015
CompletedFirst Posted
Study publicly available on registry
July 20, 2015
CompletedStudy Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2019
CompletedNovember 27, 2019
November 1, 2019
3.9 years
July 12, 2015
November 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of severity of obstructive sleep apnea, measured as apnea hypopnea index (AHI), for untreated OSA group and oral appliance group
Home sleep test is used to measure AHI.
Baseline and after 6-week exercise training
Change of severity of obstructive sleep apnea, measured as 95th percentile pressures, for PAP therapy group
95th percentile pressures (2 week period) of autotitrating CPAP will be used to assess the effects of upper airway muscle exercise on muscle strength.
Baseline and after 6-week exercise training
Secondary Outcomes (6)
Change of sleepiness measured by Epworth Sleepiness Scale (ESS)
Baseline and after 6-week exercise training
Change of sleep quality measured by Pittsburgh Sleep Quality Index (PSQI)
Baseline and after 6-week exercise training
Change of subjective quality of life measured by SF-36
Baseline and after 6-week exercise training
Change of neurocognitive function measured by psychomotor vigilance test (PVT)
Baseline and after 6-week exercise training
Change of upper airway anatomy evaluated with acoustic pharyngometry
Baseline and after 6-week exercise training
- +1 more secondary outcomes
Study Arms (4)
Untreated OSA Muscle Exercise Group
EXPERIMENTALPatients who were previously diagnosed of obstructive sleep apnea (OSA) with apnea hypopnea index (AHI) \> 10 events/hr and have previously failed or refused PAP therapy. In this group, patients will learn and practice upper airway muscle exercise for six weeks.
PAP Therapy Muscle Exercise Group
EXPERIMENTALOSA patients who are currently treated with PAP for their OSA (with AHI of previous sleep study \> 10 events/hr). In this group, patients will learn and practice upper airway muscle exercise for six weeks.
Oral Appliance Muscle Exercise Group
EXPERIMENTALOSA patients who are currently treated with an oral appliance with residual AHI \> 10 events/hr. In this group, patients will learn and practice upper airway muscle exercise for six weeks.
Normal Control Sham Exercise Group
ACTIVE COMPARATORPatients of untreated OSA group, PAP therapy group, and oral appliance group are randomized to upper airway muscle exercise versus sham exercise.
Interventions
Patients will use an individualized oral retainer device for upper airway muscle training exercises daily for 20 minutes each day (10 minutes in the morning and 10 minutes in the afternoon/evening) for 6 weeks.
Patients will be given an individualized oral retainer device and instructed to do deep breathing exercise twice daily for 6 weeks.
Eligibility Criteria
You may qualify if:
- Prior diagnosis of OSA with AHI\>10 events/hr.
- PAP group: subjects who have been on PAP treatment for at least 3 month, with good compliance (at least 4 hours a day and use PAP for \>70% of the time).
- Untreated group: untreated subjects with generally mild OSA as defined by AHI\<20 events/hr and nadir SaO2\>70%. Additionally, investigators will also recruit OSA subjects of all severities who have previously tried but are not currently using PAP.
- Oral appliance treatment group: subjects have residual AHI \>10 events/hr with oral appliance therapy.
You may not qualify if:
- In those with untreated sleep apnea, severe sleepiness with current Epworth Sleepiness Scale (ESS) \> 18 or history of motor vehicle accident due to obstructive sleep apnea
- Taking medications classified as a muscle relaxant
- Pregnant women.
- Psychiatric disorder, other than mild and controlled depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders.
- Current smokers, alcohol (\>3oz/day) or use of illicit drugs.
- More than 10 cups of beverages with caffeine (coffee, tea, soda/pop) per day.
- Unstable cardiac disease (e.g. congestive heart failure)
- Pulmonary disease (apart from well controlled mild asthma and OSA)
- Systemic neuromuscular disease
- Other systemic disease that affects breathing (e.g. stroke) or those with expected survival \< 1 year.
- Poor oral condition, including: active periodontal disease, loose or broken teeth, lack of eight teeth in each arch, active TMJ dysfunction
- Known allergy to oral appliance components
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Diego
San Diego, California, 92093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Atul Malhotra, MD
University of California, San Diego
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 12, 2015
First Posted
July 20, 2015
Study Start
August 1, 2015
Primary Completion
June 24, 2019
Study Completion
June 24, 2019
Last Updated
November 27, 2019
Record last verified: 2019-11